4//SEC Filing
Primiano Christopher Brett 4
Accession 0000899243-21-042078
CIK 0001501796other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 7:23 PM ET
Size
7.4 KB
Accession
0000899243-21-042078
Insider Transaction Report
Form 4
Primiano Christopher Brett
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-28+37,500→ 37,500 totalExercise: $14.00Exp: 2031-10-27→ Common Stock (37,500 underlying) - Award
Common Stock
2021-10-28+8,750→ 8,750 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001603510
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 7:23 PM ET
- Size
- 7.4 KB